Login / Signup
Guselkumab does not appear to influence the IgG antibody response to SARS-CoV-2.
Dillon Mintoff
Farida Benhadou
Published in:
Dermatologic therapy (2021)
Keyphrases
</>
sars cov
respiratory syndrome coronavirus